These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30850359)

  • 1. A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer.
    Sjöberg E; Meyrath M; Milde L; Herrera M; Lövrot J; Hägerstrand D; Frings O; Bartish M; Rolny C; Sonnhammer E; Chevigné A; Augsten M; Östman A
    Clin Cancer Res; 2019 Jun; 25(12):3702-3717. PubMed ID: 30850359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL14 promotes metastasis of non-small cell lung cancer through ACKR2-depended signaling pathway.
    Chang TM; Chiang YC; Lee CW; Lin CM; Fang ML; Chi MC; Liu JF; Kou YR
    Int J Biol Sci; 2023; 19(5):1455-1470. PubMed ID: 37056937
    [No Abstract]   [Full Text] [Related]  

  • 3. A Novel Autocrine CXCL14/ACKR2 Axis: The Achilles' Heel of Cancer Metastasis?
    Zhang Q; Zhou N; Wang W; Zhou S
    Clin Cancer Res; 2019 Jun; 25(12):3476-3478. PubMed ID: 30952637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CXCL14 and its anticancer role in breast cancer.
    Gu XL; Ou ZL; Lin FJ; Yang XL; Luo JM; Shen ZZ; Shao ZM
    Breast Cancer Res Treat; 2012 Oct; 135(3):725-35. PubMed ID: 22910931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties.
    Augsten M; Sjöberg E; Frings O; Vorrink SU; Frijhoff J; Olsson E; Borg Å; Östman A
    Cancer Res; 2014 Jun; 74(11):2999-3010. PubMed ID: 24710408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth.
    Augsten M; Hägglöf C; Olsson E; Stolz C; Tsagozis P; Levchenko T; Frederick MJ; Borg A; Micke P; Egevad L; Ostman A
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3414-9. PubMed ID: 19218429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer.
    Sjöberg E; Augsten M; Bergh J; Jirström K; Östman A
    Br J Cancer; 2016 May; 114(10):1117-24. PubMed ID: 27115465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells.
    Fazi B; Proserpio C; Galardi S; Annesi F; Cola M; Mangiola A; Michienzi A; Ciafrè SA
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL14 and NOS1 expression in specimens from patients with stage I-IIIA nonsmall cell lung cancer after curative resection.
    Ji X; Shen Z; Zhao B; Yuan X; Zhu X
    Medicine (Baltimore); 2018 Mar; 97(10):e0101. PubMed ID: 29517684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis.
    Xu K; Tian X; Oh SY; Movassaghi M; Naber SP; Kuperwasser C; Buchsbaum RJ
    Breast Cancer Res; 2016 Jan; 18(1):14. PubMed ID: 26821678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of cytokeratin 18 enhances BCRP-mediated multidrug resistance through induction of epithelial-mesenchymal transition and predicts poor prognosis in breast cancer.
    Shi R; Wang C; Fu N; Liu L; Zhu D; Wei Z; Zhang H; Xing J; Wang Y
    Oncol Rep; 2019 May; 41(5):3015-3026. PubMed ID: 30896886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteosarcoma Cells Secrete CXCL14 That Activates Integrin α11β1 on Fibroblasts to Form a Lung Metastatic Niche.
    Xu Y; Deng C; Chen H; Song Y; Xu H; Song G; Wang X; Luo T; Chen W; Ma J; Zeng A; Huang S; Chen Z; Fu J; Gong M; Tai Y; Huang A; Feng H; Hu J; Zhu X; Tang Q; Lu J; Wang J
    Cancer Res; 2024 Apr; 84(7):994-1012. PubMed ID: 38295227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
    Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
    Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.
    Juang YL; Jeng YM; Chen CL; Lien HC
    Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The atypical Rho GTPase RhoBTB2 is required for expression of the chemokine CXCL14 in normal and cancerous epithelial cells.
    McKinnon CM; Lygoe KA; Skelton L; Mitter R; Mellor H
    Oncogene; 2008 Nov; 27(54):6856-65. PubMed ID: 18762809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection.
    Zeng J; Yang X; Cheng L; Liu R; Lei Y; Dong D; Li F; Lau QC; Deng L; Nice EC; Xie K; Huang C
    J Transl Med; 2013 Jan; 11():6. PubMed ID: 23294544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of a new pro-invasion factor in tumor microenvironment: progress in function and mechanism of extracellular ATP].
    Fang WG; Tian XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 49(2):188-195. PubMed ID: 28416823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.
    Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G
    Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression.
    Kleer CG; Bloushtain-Qimron N; Chen YH; Carrasco D; Hu M; Yao J; Kraeft SK; Collins LC; Sabel MS; Argani P; Gelman R; Schnitt SJ; Krop IE; Polyak K
    Clin Cancer Res; 2008 Sep; 14(17):5357-67. PubMed ID: 18765527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.